125 DIHYDROXY VITAMIN D (AKU) Blood Test at Dr. Essa Lab
Book at Dr. Essa Laboratories & Diagnostic Center · karachi
Book this test
Compare other labs
Testzone Lab
125 DIHYDROXY VITAMIN D (AKU) at Dr. Essa Lab
The 125 DIHYDROXY VITAMIN D (AKU) test is a highly specialized clinical laboratory assay designed to measure the circulating levels of calcitriol, which is the biologically active form of vitamin D in the human body. Unlike the standard 25-hydroxyvitamin D test, which is commonly used to screen for nutritional vitamin D deficiency, this specific test evaluates the active hormone that directly regulates calcium and phosphorus absorption in the intestines and bone mineralization. Calcitriol is synthesized primarily in the kidneys through the enzymatic conversion of 25-hydroxyvitamin D by the 1-alpha-hydroxylase enzyme, a process tightly regulated by parathyroid hormone (PTH), calcium, and phosphate levels.
Understanding the diagnostic value of the 125 DIHYDROXY VITAMIN D (AKU) test is crucial for managing complex metabolic bone diseases and renal disorders. At Dr. Essa Lab, a premier diagnostic institution in Karachi, Pakistan, this test is performed using advanced chemiluminescence immunoassay (CLIA) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) technologies. These state-of-the-art platforms ensure high analytical sensitivity and specificity, allowing clinical pathologists to detect even minute fluctuations in active vitamin D levels. The anatomical structures indirectly evaluated through this test include the kidneys, parathyroid glands, and the skeletal system, making it an indispensable tool for endocrinologists, nephrologists, and rheumatologists.
The clinical importance of measuring 1,25-dihydroxyvitamin D lies in its ability to differentiate between various underlying causes of hypercalcemia, hypocalcemia, and metabolic bone disorders. For instance, while nutritional deficiency leads to low 25-hydroxyvitamin D, active vitamin D levels may remain normal or even elevated due to compensatory mechanisms. Conversely, in conditions like chronic kidney disease or hereditary rickets, the body cannot produce sufficient active vitamin D despite adequate precursor levels. By providing an accurate assessment of calcitriol, Dr. Essa Lab assists physicians in formulating targeted, evidence-based treatment plans for patients suffering from complex endocrine and renal pathologies.
Clinical Procedure: What to Expect
Patient Preparation
To ensure the highest degree of accuracy and to minimize potential analytical interference, patients undergoing the 125 DIHYDROXY VITAMIN D (AKU) test at Dr. Essa Lab should adhere to the following preparation guidelines:
- Fasting Requirements: While a strict fast is not always mandatory, a fasting period of 4 to 8 hours before the blood draw is highly recommended, especially if concurrent tests for calcium, phosphorus, or parathyroid hormone are scheduled.
- Supplement Disclosure: Patients must inform their healthcare provider and the laboratory staff of all vitamins, calcium supplements, and vitamin D formulations they are currently taking. High-dose biotin or active calcitriol supplements can significantly alter the test results.
- Medication Review: Certain medications, including anticonvulsants, glucocorticoids, and phosphate binders, can influence vitamin D metabolism. Discuss these with your prescribing physician prior to the test.
- Hydration: Drinking adequate amounts of plain water before the procedure is encouraged, as proper hydration makes venipuncture easier and more comfortable.
During the Procedure
The collection of the blood sample for the 125 DIHYDROXY VITAMIN D (AKU) test is a routine, safe, and quick procedure performed by the experienced phlebotomists at Dr. Essa Lab:
- Patient Positioning: The patient is asked to sit comfortably in a specialized phlebotomy chair. The arm is extended and supported on an armrest.
- Site Selection and Cleansing: The phlebotomist identifies a suitable vein, typically in the antecubital fossa (the crease of the elbow). The skin over the selected vein is thoroughly disinfected using an isopropyl alcohol swab.
- Venipuncture: A sterile, single-use needle attached to a vacuum collection tube is gently inserted into the vein. Patients may feel a brief, mild pinch or prick.
- Sample Collection: Blood is drawn into a specific serum separator tube (SST) or red-top tube. The process takes less than two minutes.
- Post-Collection Care: Once the required volume of blood is collected, the needle is carefully withdrawn, and a sterile cotton ball or gauze is pressed onto the puncture site to stop any minor bleeding. An adhesive bandage is then applied.
- Safety and Comfort: All materials used are sterile and disposable, eliminating any risk of cross-contamination. Patients can immediately resume their daily activities after the procedure.
When is a 125 DIHYDROXY VITAMIN D (AKU) Performed?
Evaluation of Chronic Kidney Disease (CKD)
Physicians frequently request this test for patients diagnosed with moderate to advanced chronic kidney disease. Because the kidneys are the primary site for converting inactive vitamin D into its active form (calcitriol), renal impairment directly compromises this metabolic pathway. Monitoring active vitamin D levels helps nephrologists diagnose renal osteodystrophy and manage secondary hyperparathyroidism effectively.
Investigation of Unexplained Hypercalcemia
When a patient presents with abnormally high blood calcium levels (hypercalcemia), identifying the root cause is critical. Elevated levels of 1,25-dihydroxyvitamin D can point toward extrarenal production, which is common in granulomatous diseases or certain malignancies. This test helps clinicians differentiate between parathyroid-dependent and parathyroid-independent hypercalcemia.
Diagnosis of Granulomatous Diseases
In inflammatory conditions such as sarcoidosis, tuberculosis, and berylliosis, active macrophages within granulomas express 1-alpha-hydroxylase independently of renal control. This leads to the autonomous and excessive production of active vitamin D, causing hypercalcemia. The 125 DIHYDROXY VITAMIN D (AKU) test is vital in confirming this pathological mechanism.
Assessment of Hereditary and Metabolic Rickets
In pediatric patients presenting with clinical signs of rickets, such as bone pain, skeletal deformities, and delayed growth, this test is instrumental. It helps differentiate between Vitamin D-Dependent Rickets Type I (characterized by a genetic mutation in the renal 1-alpha-hydroxylase enzyme, resulting in very low active vitamin D) and Type II (characterized by end-organ resistance to calcitriol, resulting in extremely high active vitamin D levels).
Monitoring Calcitriol and Parathyroid Therapy
Patients undergoing therapeutic treatment with active vitamin D preparations (calcitriol) or those recovering from parathyroid surgery require close monitoring. This test ensures that therapeutic levels are maintained within a safe, non-toxic range, preventing complications such as hypercalciuria, nephrolithiasis (kidney stones), and soft tissue calcification.
What Does a 125 DIHYDROXY VITAMIN D (AKU) Detect?
The 125 DIHYDROXY VITAMIN D (AKU) test is highly sensitive and capable of detecting a wide array of physiological and pathological states related to calcium homeostasis and bone metabolism. Specifically, this diagnostic assay can detect:
- Normal physiological levels of circulating active calcitriol, indicating balanced renal endocrine function.
- Decreased levels of active vitamin D due to progressive chronic kidney disease or end-stage renal disease (ESRD).
- Elevated active vitamin D levels caused by extrarenal synthesis in patients with active sarcoidosis.
- Increased calcitriol production associated with pulmonary or extrapulmonary tuberculosis.
- Suppressed active vitamin D levels resulting from hypoparathyroidism (deficient parathyroid hormone).
- Elevated levels associated with primary hyperparathyroidism, where excess PTH stimulates renal 1-alpha-hydroxylase.
- Low levels in pseudohypoparathyroidism, due to target organ resistance to parathyroid hormone.
- Markedly reduced active vitamin D levels in Vitamin D-Dependent Rickets Type I.
- Extremely elevated circulating levels of calcitriol in Vitamin D-Dependent Rickets Type II due to receptor mutations.
- Decreased levels associated with severe, chronic liver disease affecting the initial hydroxylation steps.
- Elevated levels in patients with certain lymphomas that produce calcitriol autonomously.
- Low active vitamin D levels in tumor-induced osteomalacia caused by excess fibroblast growth factor 23 (FGF23).
- Decreased levels in patients with X-linked hypophosphatemic rickets.
- Elevated levels due to accidental or therapeutic calcitriol (active vitamin D) toxicity.
- Normal or elevated levels in early nutritional vitamin D deficiency, where compensatory PTH elevation drives conversion.
- Low levels associated with severe, chronic magnesium deficiency, which impairs PTH secretion and action.
- Physiologically elevated levels during normal pregnancy and lactation due to increased metabolic demand.
- Decreased levels in patients with autoimmune polyglandular syndromes affecting endocrine glands.
- Reduced levels caused by long-term use of enzyme-inducing anticonvulsant medications.
- Elevated active vitamin D levels in idiopathic infantile hypercalcemia.
- Decreased levels in nephrotic syndrome due to the urinary loss of vitamin D-binding proteins.
- Elevated levels associated with berylliosis and other occupational granulomatous lung diseases.
- Elevated levels in fungal infections that trigger granulomatous responses, such as histoplasmosis and coccidioidomycosis.
- Decreased levels in patients with severe intestinal malabsorption syndromes, such as advanced celiac disease or Crohn’s disease.
Turnaround Time and Report Access at Dr. Essa Lab
At Dr. Essa Lab, we prioritize both diagnostic accuracy and patient convenience. Because the 125 DIHYDROXY VITAMIN D (AKU) test is a highly specialized, complex laboratory assay requiring advanced analytical platforms, the processing time typically spans a few working days. This timeframe allows our clinical pathologists to perform necessary quality control checks, ensuring that every result meets international diagnostic standards.
Once your report is finalized and verified, Dr. Essa Lab offers multiple convenient ways to access your results. Patients receive an automated SMS notification containing a direct link to download their electronic report. Reports can also be accessed securely through the official Dr. Essa Lab web portal or mobile application by entering the unique patient ID and password provided on the receipt. For those who prefer physical copies, printed reports can be collected from any of our diagnostic collection centers located across Karachi and other major cities in Pakistan.
125 DIHYDROXY VITAMIN D (AKU) Findings Overview
The following table outlines the clinical parameters evaluated during the 125 DIHYDROXY VITAMIN D (AKU) test, along with typical normal and abnormal findings associated with various health conditions:
| Structure / Parameter Evaluated | Normal Findings | Possible Abnormal Findings |
|---|---|---|
| Serum Calcitriol [1,25(OH)2D] | Within age-specific reference range (typically 18–64 pg/mL) | Decreased in renal failure; Elevated in granulomatous diseases |
| Renal 1-Alpha-Hydroxylase Activity | Adequate conversion of precursor to active hormone | Impaired in CKD, leading to metabolic bone disease |
| Parathyroid Hormone (PTH) Interaction | Balanced feedback loop maintaining calcium homeostasis | Suppressed in hypoparathyroidism; Elevated in primary hyperparathyroidism |
| Granulomatous Macrophage Activity | No extrarenal synthesis of active vitamin D | Unregulated, autonomous synthesis in sarcoidosis or tuberculosis |
| End-Organ Receptor Sensitivity | Normal cellular response to circulating calcitriol | Severe resistance in Vitamin D-Dependent Rickets Type II |
| Intestinal Calcium Absorption | Optimal absorption of dietary calcium and phosphorus | Severely reduced in calcitriol deficiency, leading to osteomalacia |
| Skeletal Mineralization Status | Healthy bone density and normal osteoid mineralization | Impaired mineralization, resulting in rickets (pediatric) or osteomalacia (adults) |
Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.
Why Choose Dr. Essa Lab for 125 DIHYDROXY VITAMIN D (AKU)?
- Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified clinical pathologists, biochemists, and technologists specializing in complex endocrine assays.
- Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality at every stage of the diagnostic process.
- Quality Diagnostic Services: Dr. Essa Lab adheres to strict internal and external quality control protocols to ensure international standards of accuracy.
- Professional Reporting: Reports are verified through a multi-level review process to eliminate errors and provide clear, actionable clinical data.
- Modern Diagnostic Approach: We utilize state-of-the-art laboratory equipment and advanced testing methodologies for high-complexity assays.
- Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and stress-free environment for all patients.
- Convenient Locations: With an extensive network of diagnostic centers across Karachi and other major cities, accessing our services is highly convenient.
- Commitment to Accurate Diagnosis: We are dedicated to providing timely and precise diagnostic insights to support your physician’s treatment decisions.